期刊文献+

人干扰素λ1基因启动子荧光素酶报告基因质粒的构建及其转录活性分析 被引量:2

Construction and transcriptional activity of recombinant plasmid containing human interferon λ1 gene promoter luciferase reporter gene
原文传递
导出
摘要 目的构建人干扰素λ1(interferonλ1,IFNλ1)基因启动子荧光素酶报告基因载体,并探讨仙台病毒及质粒IRF3-5D和HA-IRF7对其转录活性的影响。方法提取BEAS-2B细胞基因组DNA,以其为模板,PCR扩增IFNλ1基因启动子,插入荧光素酶报告基因载体pGL3-enhancer,构建IFNλ1基因启动子荧光素酶报告基因质粒IFNL1-luc,将其转染293T细胞,同时用质粒IFNβ-luc和pGL3-enhancer转染作为对照。转染24 h后感染仙台病毒,于感染前和感染后4、12、18和24 h收集细胞,进行双荧光素酶活性检测;用质粒IRF3-5D或HA-IRF7与质粒IFNL1-luc共转染,36 h后收集细胞,进行双荧光素酶活性检测。结果 IFNλ1基因启动子荧光素酶报告基因质粒IFNL1-luc经双酶切及测序鉴定,证明构建正确;分别转染质粒IFNL1-luc和IFNβ-luc的细胞感染仙台病毒后,荧光素酶活性倍数均随时间延长呈明显上升趋势,至18 h达到峰值(分别为1 000倍和2 300倍),转染质粒pGL3-enhancer的细胞感染仙台病毒后,不同时间点收集的细胞,荧光素酶活性倍数一直处于较低水平;质粒HA-IRF7或IRF3-5D对IFNL1-luc的活化倍数明显高于pGL3-enhancer(P<0.05)。结论成功构建了IFNλ1基因启动子荧光素酶报告基因质粒IFNL1-luc,仙台病毒及质粒IRF3-5D和HA-IRF7均能激活IFNL1-luc的转录,为进一步研究调控IFNλ1表达的信号转导通路奠定了基础。 Objective To construct the recombinant plasmid containing human interferon (IFN)λ 1 promoter recombined luciferase reporter gene, and investigate the effect of plasmids IRF3-5D and HA-IRF7 on its transcriptional activity, Methods The promoter of human IFNkl gene was amplified by PCR using the extracted genomic DNA of BEAS-2B cells as a template, and inserted into the luciferase reporter vector pGL3-enhancer. The constructed recombinant plasmid IFNLI-luc was transfected to 293T cells, using plasmid IFN-β-luc and pGL3-enhancer as controls. The ceils were infected with Sendal virus 24 h after transfection. The cells were collected before and 4, 12, 18 and 24 h after infection, and determined for luciferase activity. The ceils were co-transfected with plasmids IFNLI-luc and IRF3-5D or HA-IRFT, and collected 36 h later for determination of luciferase activity. Results Both restriction analysis and sequencing proved that recombinant plasmid IFNLI-luc was constructed correctly. The folds of luciferase activation of cells transfected with plasmids IFNL1-luc and IFNβ-luc increased significantly and reached peak values of 1 000 and 2 300 18 h after infection with Sendal virus. However, the folds of luciferase activation of cells transfected with pGL3-enhancer were maintained at low levels at various time points after infection with Sendal virus. The activation folds of plasmids HA- IRF7 or IRF3-5D to IFNL1-luc were significantly higher than that of pGL3-enhancer (P 〈 0. 05 ). Conclusion The recombinant plasmid IFNL1-lue containing human interferon (IFN) λ1 promoter recombined luciferase reporter gene was constructed successfully. Sendal virus as well as plasmids IRF3-5D and HA-IRF7 activated the transcription of IFNL1-luc, which laid a foundation of further study on the signaling pathway regulating IFNλI expression.
出处 《中国生物制品学杂志》 CAS CSCD 2014年第6期752-755,760,共5页 Chinese Journal of Biologicals
关键词 干扰素λ1 启动子 双荧光素酶报告基因 仙台病毒 转录 活性 Interferonλ1 Promoter Dual luciferase reporter gene Sendal virus Transcription Activity
  • 相关文献

参考文献16

  • 1González-Navajas JM,Lee J,David M,et al.Immunomodulatory functions of type I interferons[J].Nat Rev Immunol,2012,12(2):125-135.
  • 2Kotenko SV,Gallagher G,Baurin VV,et al.IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex[J].Nat Immunol,2003,4(1):69-77.
  • 3Sheppard P,Kindsvogel W,Xu W,et al.IL-28,IL-29 and their class II cytokine receptor IL-28R[J].Nat Immunol,2003,4(1):63-68.
  • 4Prokunina-Olsson L,Muchmore B,Tang W,et al.A variant upstream of IFNL3(IL28B)creating a new interferon gene IFNL4is associated with impaired clearance of hepatitis C virus[J].Nat Genet,2013,45(2):164-171.
  • 5Amanzada A,Kopp W,Spengler U,et al.Interferon-lambda4(IFNL4)transcript expression in human liver tissue samples[J].PLoS One,2013,8(12):e84026.
  • 6Crotta S,Davidson S,Mahlakoiv T,et al.Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia[J].PLoS Pathog,2013,9(11):e1003773.
  • 7Jordan WJ,Eskdale J,Boniotto M,et al.Modulation of the human cytokine response by interferon lambda-1(IFN-lambda1/IL-29)[J].Genes Immun,2007,8(1):13-20.
  • 8Contoli M,Message SD,Laza-Stanca V,et al.Role of deficient type III interferon-lambda production in asthma exacerbations[J].Nat Med,2006,12(9):1023-1026.
  • 9Forbes RL,Gibson PG,Murphy VE,et al.Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma[J].Thorax,2012,67(3):209-214.
  • 10Kaukinen P,Sillanpaa M,Kotenko S,et al.Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine emokine gene expression[J].Virol J,2006,3:66.

同被引文献28

  • 1Zoladz PR, Diamond DM. Current status on behavioral and biological markers of PTSD: a search for clarity in a con- flicting literature [J]. Neurosci Biobehav Rev, 2013,37 (5) : 860-895.
  • 2Hemmings SM,Li M,Marisa K. BDNF Va166Met and DRD2 TaqlA polymorphisms interact to influence PTSD symptom severity: a preliminary investigation in a South African population [J]. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2013, g0 (2) : 273 -280.
  • 3Vasconcelos AC,Neto Ede S,Pinto GR,et aL Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 TaqlA poly- morphisms with alcohol dependence in a population from northeastern Brazil [J]. Alcohol Clin Exp Res,2015,39(2) : 205-211.
  • 4Kang SG,Na KS,Lee HJ,et al. DRD2 genotypic and hap- lotype variation is associated with improvements in nega- tive symptoms after 6 weeks" amisulpride treatment [J]. J Clin Psychopharmacol, 2015,35(2) : 158-162.
  • 5Yao J, Wang B. Response to "DRD2 Ser311Cys Polymor- phism and risk of schizophrenia"[J]. Am J Med Genet Part B,2015(3) :223.
  • 6Pan YQ, Qiao L,Xue XD, et al. Association between ANKK 1 (rs1800497) polymorphism of DRD2 gene and attention :le?cit hyperactivity disorder:a meta-analysis [J]. Neuro- ~cience Letters, 2015,590 ( 1 ) : 101-105.
  • 7Comings DE, Muhleman D, Gysin R. Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder:a study and replication [J]. Biol. Psychiatry, 1996, 40(5) : 368-372.
  • 8Duan J,Wainwright MS, Comeron JM,et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor [J]. Hum Mol Genet, 2003,12 (3) : 205-216.
  • 9Jonsson EG,Nothen MM,Grunhage F,et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volun- teers [J]. Mol Psychiatry, 1999,4(2):290-296.
  • 10Hirvonen MM,Laakso A,Nagren K,et al. C957T polymor- phism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affin- ity [J]. Synapse, 2009,63 (4) : 907-912.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部